CRB
CVS icon

Chad R. Baker’s CVS Health CVS Stock Holding History

Chad R. Baker’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-96,605
Closed -$7.71M – 52
2024
Q1 		$7.71M Buy
96,605
+455
+0.5% +$34.8K 1.64% 24
2023
Q4 		$7.59M Hold
96,150
– – 1.71% 25
2023
Q3 		$6.71M Buy
96,150
+435
+0.5% +$30.8K 1.69% 23
2023
Q2 		$6.62M Buy
95,715
+2,645
+3% +$188K 1.56% 25
2023
Q1 		$6.92M Buy
93,070
+2,265
+2% +$190K 1.76% 25
2022
Q4 		$8.46M Hold
90,805
– – 2.37% 17
2022
Q3 		$8.66M Hold
90,805
– – 2.47% 16
2022
Q2 		$8.41M Hold
90,805
– – 2.34% 17
2022
Q1 		$9.19M Hold
90,805
– – 2.07% 20
2021
Q4 		$9.37M Hold
90,805
– – 1.94% 23
2021
Q3 		$7.71M Sell
90,805
-375
-0.4% -$31.4K 1.73% 27
2021
Q2 		$7.61M Hold
91,180
– – 1.71% 27
2021
Q1 		$6.86M Hold
91,180
– – 1.64% 28
2020
Q4 		$6.23M Hold
91,180
– – 1.52% 28
2020
Q3 		$5.33M Hold
91,180
– – 1.43% 32
2020
Q2 		$5.92M Buy
91,180
+6,000
+7% +$378K 1.78% 25
2020
Q1 		$5.05M Buy
85,180
+26,000
+44% +$1.74M 1.96% 24
2019
Q4 		$4.4M Buy
+59,180
New +$4.16M 1.46% 28
2018
Q2 		– Sell
-47,705
Closed -$2.97M – 58
2018
Q1 		$2.97M Hold
47,705
– – 1.17% 36
2017
Q4 		$3.46M Sell
47,705
-21,300
-31% -$1.55M 1.37% 32
2017
Q3 		$5.61M Buy
69,005
+325
+0.5% +$25.7K 2.21% 17
2017
Q2 		$5.53M Hold
68,680
– – 2.19% 18
2017
Q1 		$5.39M Buy
68,680
+1,275
+2% +$102K 2.19% 16
2016
Q4 		$5.32M Sell
67,405
-500
-0.7% -$40.5K 2.35% 15
2016
Q3 		$6.04M Hold
67,905
– – 2.6% 9
2016
Q2 		$6.5M Hold
67,905
– – 2.9% 7
2016
Q1 		$7.04M Sell
67,905
-525
-0.8% -$51K 3.2% 6
2015
Q4 		$6.69M Buy
+68,430
New +$6.7M 2.99% 7

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Chad R. Baker's CVS Position: Q2 2024 in Review

Chad R. Baker sold out of CVS Health (CVS) in Q2 2024, closing a stake of 96,605 shares — an estimated $7.71M sold.

Chad R. Baker first reported a position in CVS in Q4 2015 and held it in 28 quarters. The position peaked at $9.37M in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Chad R. Baker reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Chad R. Baker sold 96,605 CVS Health shares in Q2 2024, an estimated $7.71M.
  • Chad R. Baker first reported a position in CVS Health in Q4 2015 and held it in 28 quarters.
  • Chad R. Baker's CVS Health position peaked at $9.37M in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Chad R. Baker's 13F filing for Q2 2024, filed 22 Jul 2024.